Matt Kaplan

Matt Kaplan

Director/Board Member at NUVECTIS PHARMA, INC.

Net worth: 365 648 $ as of 2024-05-30

56 year
Finance
Consumer Services
Health Technology

Profile

Mr. Matt L.
Kaplan
is a Managing Director & Head of Equity Research at Ladenburg Thalmann & Co., Inc. He has over 14 years of experience as a biotechnology analyst.
His current research focus is therapeutic companies, cardiovascular, and drug delivery.
Prior to joining Ladenburg Thalmann, he was a Partner and the Director of Healthcare Research with Punk, Ziegel & Company.
Previously, he was a Senior Biotechnology Analyst at Evolution Capital and a Director of The Life Sciences Group at The Carson Group.
Before joining The Carson Group and Evolution Capital, Mr. Kaplan had six years of experience as a Research Associate with the Albert Einstein College of Medicine/Montefiore Hospital Department of Cardiology.
Mr. Kaplan received his bachelor’s degree in Biology from the University of Michigan and studied Cellular and Molecular Biology at Columbia University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-14 54,010 ( 0.29% ) 365 648 $ 2024-05-30

Matt Kaplan active positions

CompaniesPositionStart
NUVECTIS PHARMA, INC. Director/Board Member 2021-08-31
Director of Research - Equity 2008-05-01
All active positions of Matt Kaplan

Former positions of Matt Kaplan

CompaniesPositionEnd
Analyst-Equity 2008-04-30
Corporate Officer/Principal 2003-10-31
Albert Einstein College of Medicine, Inc. Corporate Officer/Principal -
See the detail of Matt Kaplan's experience

Training of Matt Kaplan

University of Michigan Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matt Kaplan's experience

Connections

69

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
NUVECTIS PHARMA, INC.

Health Technology

Private companies3

Finance

Finance

Finance

See company connections